Absolutely not opposed to the latter, vaccines are and have been of tremendously huge benefit to humanity.
Not the full spectrum, the trials are still ongoing. That’s why they have, in the US (and the equivalent in many other jurisdictions) Emergency Use Authorizations, not regular approvals.
Each of the Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson & Johnson vaccines all have Conditional Marketing Authorisation in the EU.
The EU contrasts this as being much more robust and stringent that a mere Emergency Use Authorisation.
See the section “What are the different data requirements between an Emergency Use Authorisation and a Conditional Marketing Authorisation, and what are the potential consequences of these?” https://ec.europa.eu/commission/presscorner/detail/en/qanda_...